Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

BMAL1-TRIM28 represses transposable elements independently of CLOCK in pluripotent cells

  • Gallardo, Amador
  • Belmonte-Reche, Efres
  • Marti, María
  • Domingo, Joan
  • Peris, Guillermo
  • López Onieva, Lourdes
  • Fernández-Rengel, Iván
  • Xie, Jiajun
  • Tristán Ramos, Pablo
  • Bellora, Nicolás
  • Sánchez Pozo, Antonio
  • Estévez, Antonio M.
  • Heras, Sara R.
  • Marti Renom, Marc A.
  • Landeira, David
Datasets are available at GEO-NCBI with accession number GSE263285. Raw proteomics data has been deposited in PRIDE repository with identifier PXD050769, Circadian oscillations of gene transcripts rely on a negative feedback loop executed by the activating BMAL1-CLOCK heterodimer and its negative regulators PER and CRY. Although circadian rhythms and CLOCK protein are mostly absent during embryogenesis, the lack of BMAL1 during prenatal development causes an early aging phenotype during adulthood, suggesting that BMAL1 performs an unknown non-circadian function during organism development that is fundamental for healthy adult life. Here, we show that BMAL1 interacts with TRIM28 and facilitates H3K9me3-mediated repression of transposable elements in naïve pluripotent cells, and that the loss of BMAL1 function induces a widespread transcriptional activation of MERVL elements, 3D genome reorganization and the acquisition of totipotency-associated molecular and cellular features. We propose that during embryogenesis, BMAL1 is redeployed as a transcriptional repressor of transposons in a CLOCK-independent way, and the activity of BMAL1-TRIM28 during prenatal life might protect mammalian organisms from premature aging during adulthood., We thank the core facilities at the Center for Genomics and Oncological Research (GENYO), including the cytometry and microscopy units for excellent technical assistance. We also thank the Centro Nacional de Análisis Genómico (CNAG) and the proteomics facility at the Center for Genomic Regulation (CRG) for support with ChIP-seq, mRNA-seq and proteomic experiments. We are grateful to Maria-Elena Torres-Padilla for providing useful scientific advice during the review process. Work in the Landeira lab is supported by the Carlos III Health Institute from European funds under the Recovery, Transformation, and Resilience Plan, file code IHRC22/00007, pursuant to Resolution of the Management of the Carlos III Health Institute, O.A., M.P. of December 22, 2022, granting ISCIII-HEALTH Seal of Excellence subsidies, and funded by the European Union - NextGenerationEU, the Spanish ministry of science and innovation (PID2019-108108-100, EUR2021-122005, PID2022-137060NB-I00), the Andalusian regional government (PIER-0211-2019, PY20_00681), and the University of Granada (A-BIO-6-UGR20) grants. The Marti-Renom lab acknowledges support from the Spanish Ministry of Science and Innovation (PID2020-115696RB-I00) as well as the Catalan Government through the AGAUR agency (SGR 01127). The work in Sara R. Heras' lab was supported by the Spanish Ministry of Science and Innovation (PID2020-115033RB-I00, RYC-2016-21395, CNS2023-145402) and the Andalusian regional government (PY20_00619 y A-CTS-28_UGR20) grants. We thank the IMPULSE visitor programme Severo Ochoa 2022 for funding Amador Gallardo to carry out chromosome conformation capture experiments at the CRG. Efres Belmonte Reche was supported by a Maria Zambrano fellowship financed by NextGenerationEU/European Union., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Control of retrotransposon-driven activation of the interferon response by the double-stranded RNA binding protein DGCR8

  • Gázquez-Gutiérrez, Ana
  • Chin, Priscilla
  • Peris, Guillermo
  • Gordon, Katrina
  • Marchante, Pilar G.
  • Witteveldt, Jeroen
  • Tristán Ramos, Pablo
  • Rouvière, Jerome O.
  • Knol, Lisanne I.
  • Ivens, Alasdair
  • López Onieva, Lourdes
  • Estévez, Antonio M.
  • Garland, William
  • Jensen, Torben H.
  • Heras, Sara R.
  • Macías, Sara
All high-throughput RNA sequencing datasets have been deposited in the GEO database. Both total and small-RNA seq from WT and DGCR8 KO cells can be accessed at GSE294708 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294708). The dsRNA-seq data for both WT and DGCR8 KO cells can be accessed at GSE294748 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294748). Mass spectrometry proteomics data have been deposited in PRIDE and can be accessed at PXD074388, https://www.ebi.ac.uk/pride/archive/projects/PXD074388. The new bioinformatic pipeline can be found at https://github.com/GuillePeris/TE_feature_density and https://doi.org/10.5281/zenodo.18611327., The type I interferon (IFN) response is the main innate immune pathway against viruses in mammals. This pathway must be tightly regulated to prevent viral spread while avoiding excessive immune responses. Here, we show that inactivation of the double-stranded RNA (dsRNA)-binding protein DGCR8 unleashes the IFN response in human cells. We demonstrate that DGCR8 restricts the accumulation of endogenous dsRNA originating from protein-coding mRNAs that harbour transposable elements (TEs), primarily LINE and SINE elements. We propose that DGCR8 binding to TE-rich mRNAs is essential to resolve dsRNA structures, and in its absence, accumulated dsRNA signals through the MDA5-MAVS pathway trigger the IFN response. This mechanism is relevant to conditions where DGCR8 expression levels are altered, including the 22q11.2 deletion syndrome (22qDS). Supporting this, we show that 22qDS-derived cells exhibit an exacerbated type I IFN response, which inversely correlated with DGCR8 levels. All these together demonstrate the importance of suppressing endogenous TE-dsRNA accumulation to prevent unwanted immune activation and associated disease pathogenesis., This work has been funded by the Wellcome Trust [221737/Z/20/Z and 107665/Z/15/Z]; the Royal Society grant [RGS\R1\191368] and the Wellcome Trust iTPA [PII021] (to S.M.); Grant CNS2023-145402 funded by MICIU/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”; the Spanish Ministry of Science and Innovation (PID2020-115033RB-I00); Career Integration Grant-Marie Curie (FP7-PEOPLE-2011-CIG-303812); the Andalusian Regional Government (PY20_00619, A-CTS-28_UGR20, and DGP_PIDI_2024_02576) grants and donation to “Aula de estudios 22qDS” (to S.R.H.); the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación, and European Union [PRE2021-098878] and EMBO Scientific Exchange Grant [SEG11137] (to A.G.-G.); MRC—Precision Medicine fellowship (to L.K.); Darwin Trust fellowship (to P.C.). Work in the T.H.J. laboratory was supported by the Independent Research Fund Denmark - Medical Sciences and the Novo Nordisk Foundation (NNF, ExoAdapt Grant 31199). Funding to pay the Open Access publication charges for this article was provided by the University of Edinburgh - Open Access fund., Peer reviewed, Modelo experimental alternativo-NAM, in silico